Joint Discrete and SE(3) Diffusion for Protein Interface Design
Organizations: Language Technologies Institute, Carnegie Mellon University · Lambda Inc.
Abstract
The design of high-affinity, target-specific protein binders is central to the development of modern therapeutics. However, existing protein-generation methods remain limited in this setting, as many generated designs fail to simultaneously achieve geometric and physicochemical complementarity at binding interfaces. To address this challenge, we introduce PIDiff, a physicochemically enhanced multimodal diffusion framework for protein-protein complex design. PIDiff jointly designs target-conditioned protein sequences and structures by coupling diffusion in discrete sequence space with diffusion on the continuous (SE(3)) structural manifold. At its core, PIDiff employs PIFormer, a novel architecture that interleaves geometry-aware invariant point attention with global sequence self-attention. We further curate PIBench, a protein-protein complex dataset with diverse target scaffolds derived from the Protein Data Bank (PDB). We first pretrain PIDiff on PIBench and subsequently fine-tune it for two therapeutically relevant applications: minibinder design and antibody design. PPFrame consistently outperforms baseline methods across sequence design success rate, structure binding energy, and sequence-structure co-designability on all tasks.
Figures & tables
| Models | Sequence | Structure | Co-designability ( ) | |||||
|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | Diversity ( ) | Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.523 | 81.61 | 21.73% | 37.90% | 73.01% | -45.97 | 50.00% | 50.00% |
| APM | 0.252 | 77.66 | 2.17% | 31.26% | 53.27% | -45.12 | 23.91% | 34.78% |
| Complexa | 0.521 | 84.61 | 30.43% | 53.77% | 82.69% | -56.57 | 56.52% | 54.34% |
| PIDiff | 0.592 | 87.18 | 47.83% | 33.22% | 57.49% | -67.80 | 65.22% | 65.22% |
| Models | FGFR2 (Seen) | InsulinR (Seen) | PDGFR (Seen) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| SR ( ) | G ( ) | Consistency ( ) | SR ( ) | G ( ) | Consistency ( ) | SR ( ) | G ( ) | Consistency ( ) | |
| RFD+IF | 36.84% | -42.04 | 63.15% | 56.52% | -35.35 | 65.21% | 3.84% | -59.37 | 53.84% |
| APM | 29.82% | -37.02 | 54.38% | 43.47% | -31.04 | 82.61% | 0.0 | -61.54 | 61.53% |
| Complexa | 54.38% | -45.81 | 73.68% | 78.26% | -41.32 | 86.95% | 19.23% | -66.56 | 88.46% |
| PIDiff | 61.40% | -50.87 | 98.24% | 86.95% | -46.92 | 100% | 7.69% | -68.82 | 30.76% |
| Models | TGFb (Seen) | VirB8 (Seen) | EGFR (Zero-shot) | ||||||
| Models | Sequence | Structure | Co-designability ( ) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | H1-Novelty ( ) | H2-Novelty ( ) | H3-Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.508 | 80.05 | 16.79% | 47.30% | 56.22% | 61.98% | -33.09 | 59.29% | 59.29% |
| APM | 0.256 | 77.92 | 6.61% | 45.71% | 54.17% | 64.43% | -26.68 | 53.57% | 52.74% |
| Complexa | 0.515 | 81.08 | 16.92% | 53.80% | 66.26% | 71.91% | -32.80 | 90.26% | 92.32% |
| PIDiff | 0.526 | 81.41 | 18.77% | 52.31% | 67.85% | 71.93% | -44.46 | 98.34% | 99.39% |
Appendix figures & tables18 assets
Supplementary material from the paper’s appendix.
Appendix
| Complex | |
| Training | 602,129 |
| Validation | 189 |
| Test | 46 |
| Total | 602,364 |
| Models | Seen Class | Zero-Shot | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| FGFR2 | InsulinR | PDGFR | TGFb | VirB8 | H3 | IL7Ra | EGFR | TrkA | Tie2 | |
| Training | 465 | 192 | 210 | 77 | 57 | – | – | – | – | – |
| Validation | 57 | 23 | 26 | 9 | 7 | – | – | – | – | – |
| Test | 57 | 23 | 26 | 9 | 7 | 38 | 7 | 4 | 4 | 2 |
| Total | 579 | 238 | 262 | 95 | 71 | 38 | 7 | 4 | 4 | 2 |
| CDR-H1 Clustering | CDR-H2 Clustering | CDR-H3 Clustering | |
| Complexes | 4,261 | 4,261 | 4261 |
| Clusters | 1,034 | 1,418 | 2,254 |
| Training | 3,590 | 3,576 | 3,427 |
| Validation | 403 | 399 | 451 |
| Test | 268 | 286 | 383 |
| Structure Diversity ( ) | |
|---|---|
| RFD+ProteinMPNN | 0.3097 |
| APM | 0.3063 |
| Proteína-Complexa | 0.1597 |
| PIDiff | 0.3135 |
| Models | Sequence | Structure | Co-designability ( ) | |||||
|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | Diversity ( ) | Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.637 | 78.92 | 36.84% | 31.97% | 68.25% | -42.04 | 63.15% | 63.15% |
| APM | 0.538 | 76.39 | 29.82% | 29.05% | 48.39% | -37.02 | 71.92% | 54.38% |
| Complexa | 0.823 | 80.67 | 54.38% | 49.25% | 76.91% | -45.81 | 91.22% | 73.68% |
| PIDiff | 0.931 | 82.58 | 61.40% | 41.75% | 77.74% | -50.87 | 100% | 98.24% |
| Models | Sequence | Structure | Co-designability ( ) | |||||
|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | Diversity ( ) | Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.789 | 80.43 | 56.52% | 30.89% | 69.18% | -35.35 | 65.21% | 65.21% |
| APM | 0.562 | 79.01 | 43.47% | 26.91% | 52.91% | -31.04 | 78.26% | 82.61% |
| Complexa | 0.832 | 86.90 | 78.26% | 41.93% | 76.93% | -41.32 | 100% | 86.95% |
| PIDiff | 0.895 | 93.04 | 86.95% | 27.54% | 79.51% | -46.92 | 100% | 100% |
| Models | Sequence | Structure | Co-designability ( ) | |||||
|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | Diversity ( ) | Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.598 | 76.56 | 3.84% | 28.93% | 72.83% | -59.37 | 53.84% | 53.84% |
| APM | 0.391 | 73.89 | 0.0 | 30.27% | 52.19% | -61.54 | 65.38% | 61.53% |
| Complexa | 0.652 | 78.09 | 19.23% | 41.25% | 79.42% | -66.56 | 88.46% | 88.46% |
| PIDiff | 0.678 | 81.73 | 7.69% | 25.78% | 82.43% | -68.82 | 100% | 30.76% |
| Models | Sequence | Structure | Co-designability ( ) | |||||
|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | Diversity ( ) | Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.589 | 76.90 | 11.11% | 35.17% | 68.23% | -31.09 | 55.56% | 55.56% |
| APM | 0.461 | 72.10 | 11.11% | 32.81% | 48.65% | -23.16 | 77.78% | 11.11% |
| Complexa | 0.683 | 80.15 | 22.22% | 46.17% | 76.12% | -46.54 | 88.89% | 33.33% |
| PIDiff | 0.733 | 78.17 | 22.22% | 48.57% | 76.46% | -49.29 | 100% | 22.22% |
| Models | Sequence | Structure | Co-designability ( ) | |||||
|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | Diversity ( ) | Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.570 | 82.89 | 14.28% | 32.95% | 72.91% | -32.90 | 57.14% | 57.14% |
| APM | 0.368 | 85.09 | 0.0 | 30.19% | 52.87% | -19.59 | 71.74% | 42.85% |
| Complexa | 0.602 | 86.10 | 14.28% | 46.52% | 80.15% | -38.56 | 85.71% | 85.71% |
| PIDiff | 0.657 | 86.67 | 14.28% | 36.17% | 81.16% | -48.31 | 100% | 100% |
| Models | Sequence | Structure | Co-designability ( ) | |||||
|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | Diversity ( ) | Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.571 | 83.09 | 25.00% | 29.15% | 71.26% | -46.87 | 25.00% | 25.00% |
| APM | 0.512 | 83.19 | 0.0 | 27.93% | 51.34% | -32.76 | 50.00% | 50.00% |
| Complexa | 0.627 | 86.76 | 0.0 | 40.16% | 76.31% | -40.90 | 100% | 50.00% |
| PIDiff | 0.680 | 90.19 | 0.0 | 22.62% | 82.56% | -48.35 | 100% | 100% |
| Models | Sequence | Structure | Co-designability ( ) | |||||
|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | Diversity ( ) | Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.782 | 78.56 | 52.63% | 28.16% | 71.04% | -35.93 | 26.31% | 26.31% |
| APM | 0.562 | 76.29 | 47.38% | 23.91% | 53.16% | -36.45 | 49.87% | 42.10% |
| Complexa | 0.891 | 79.05 | 60.52% | 38.16% | 80.47% | -40.65 | 78.93% | 47.36% |
| PIDiff | 0.934 | 82.32 | 97.36% | 21.97% | 83.16% | -47.08 | 100% | 31.57% |
| Models | Sequence | Structure | Co-designability ( ) | |||||
|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | Diversity ( ) | Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.543 | 85.67 | 14.28% | 29.18% | 70.19% | -40.08 | 42.85% | 42.85% |
| APM | 0.429 | 78.09 | 0.0 | 27.56% | 53.96% | -23.93 | 85.71% | 57.14% |
| Complexa | 0.634 | 89.90 | 28.57% | 36.17% | 80.16% | -42.26 | 100% | 71.42% |
| PIDiff | 0.734 | 92.21 | 42.85% | 20.35% | 82.30% | -50.42 | 100% | 100% |
| Models | Sequence | Structure | Co-designability ( ) | |||||
|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | Diversity ( ) | Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.562 | 86.90 | 50.00% | 29.31% | 72.91% | -38.95 | 75.00% | 75.00% |
| APM | 0.421 | 82.19 | 0.0 | 30.19% | 51.43% | -27.85 | 100% | 50.00% |
| Complexa | 0.590 | 90.10 | 0.0 | 39.42% | 81.58% | -33.83 | 100% | 50.00% |
| PIDiff | 0.635 | 92.98 | 0.0 | 10.52% | 88.20% | -42.39 | 100% | 100% |
| Models | Sequence | Structure | Co-designability ( ) | |||||
|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | Diversity ( ) | Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.791 | 72.08 | 25.00% | 28.17% | 70.16% | -33.28 | 50.00% | 50.00% |
| APM | 0.563 | 73.90 | 25.00% | 31.42% | 49.87% | -31.92 | 75.00% | 25.00% |
| Complexa | 0.829 | 80.10 | 50.00% | 47.92% | 78.93% | -41.50 | 100% | 50.00% |
| PIDiff | 0.840 | 80.31 | 75.00% | 35.49% | 78.92% | -46.04 | 100% | 75.00% |
| Models | Sequence | Structure | Co-designability ( ) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | H1-Novelty ( ) | H2-Novelty ( ) | H3-Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.538 | 80.67 | 15.67% | 49.78% | 51.26% | 59.31% | -30.03 | 58.20% | 58.20% |
| APM | 0.239 | 79.23 | 7.46% | 42.18% | 53.37% | 63.17% | -29.38 | 57.08% | 52.61% |
| Complexa | 0.523 | 81.09 | 14.92% | 55.36% | 68.26% | 72.93% | -35.35 | 88.43% | 90.67% |
| PIDiff | 0.548 | 82.10 | 17.16% | 56.64% | 66.46% | 74.68% | -42.49 | 100% | 100% |
| Models | Sequence | Structure | Co-designability ( ) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | H1-Novelty ( ) | H2-Novelty ( ) | H3-Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.497 | 79.29 | 17.48% | 43.87% | 58.69% | 62.89% | -32.98 | 58.04% | 58.04% |
| APM | 0.271 | 76.32 | 5.59% | 45.28% | 52.97% | 63.16% | -28.78 | 52.98% | 53.14% |
| Complexa | 0.519 | 81.90 | 17.83% | 52.79% | 65.23% | 70.95% | -30.13 | 91.25% | 93.35% |
| PIDiff | 0.506 | 80.62 | 19.58% | 49.38% | 67.21% | 69.61% | -44.37 | 100% | 100% |
| Models | Sequence | Structure | Co-designability ( ) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| ipTM ( ) | pLDDT ( ) | SR ( ) | H1-Novelty ( ) | H2-Novelty ( ) | H3-Novelty ( ) | G ( ) | Designability ( ) | ||
| RFD+IF | 0.487 | 80.17 | 17.23% | 48.26% | 58.73% | 63.75% | -36.25 | 61.62% | 61.62% |
| APM | 0.259 | 78.23 | 6.78% | 49.67% | 56.19% | 66.97% | -21.89 | 50.65% | 52.48% |
| Complexa | 0.502 | 80.26 | 18.01% | 53.26% | 65.29% | 71.86% | -32.90 | 91.12% | 92.95% |
| PIDiff | 0.525 | 81.50 | 19.58% | 50.88% | 69.85% | 71.51% | -46.53 | 95.03% | 98.17% |
| Models | FGFR2 (Seen) | InsulinR (Seen) | PDGFR (Seen) | ||||||
|---|---|---|---|---|---|---|---|---|---|
| SR ( ) | G ( ) | Consistency ( ) | SR ( ) | G ( ) | Consistency ( ) | SR ( ) | G ( ) | Consistency ( ) | |
| PIDiff | 61.40% | -50.87 | 98.24% | 86.95% | -46.92 | 100% | 7.69% | -68.82 | 30.76% |
| w/o finetuning | 5.52% | -55.88 | 100% | 8.69% | -44.08 | 100% | 0.0 | -72.28 | 100% |
| Models | TGFb (Seen) | VirB8 (Seen) | EGFR (Zero-shot) | ||||||
| SR ( ) | G ( ) | Consistency ( ) | SR ( ) | G ( ) | Consistency ( ) | SR ( ) | G ( ) | Consistency ( ) | |
| PIDiff | 22.22% | -49.29 | 22.22% | 14.28% | -48.31 | 100% | 0.0 | -48.35 | 100.0% |
Protein Binder Design
Protein binder design creates proteins, antibodies, and peptides that bind selected molecular targets with desired specificity and function.
See all 23 papers